Abstract
The aim of this study was to estimate the validity of mass screening for gastric cancer using serum pepsinogens (PG test). The study subjects were 4876 workers aged from 40 to 61 years old. Sera were obtained at the time of the health checkup and serum pepsinogen levels (PG I and PG II) were measured at the same time. PG I < 50 ng/ml and PG I/PG II ratio < 3.0 were adopted as the criteria for a positive result for the PG test. PG test‐positive subjects were examined, in principle, by endoscopy. Furthermore, all the subjects were followed up for a year to check for occurrence of gastric cancer. Among the total subjects, 911 (18.7%) were positive for the PG test and 650 (71.4%) among the positive subjects underwent further examinations, which revealed 11 cases of gastric cancer. Seven gastric cancer cases were diagnosed during the follow‐up period within one year after the PG test. Six out of the 7 cancer cases had been negative in the PG test. When the results of one year's follow‐up from the time of screening were defined as the gold standard, the sensitivity and specificity of the PG test were estimated at 66.7% and 81.5%, respectively. The authors conclude that the validity of the PG test as a mass screening method may be comparable to that of X‐ray screening, if optimum criteria of a positive test are selected.
Keywords: Serum pepsinogen, Gastric cancer, Mass screening, Sensitivity and specificity
Full Text
The Full Text of this article is available as a PDF (416.9 KB).
REFERENCES
- 1. ) Parkin , D. M. , Läärä , E. and Muir , C. S.Estimates of the worldwide frequency of sixteen major cancers in 1980 . Int. J. Cancer , 41 , 184 – 197 ( 1988. ). [DOI] [PubMed] [Google Scholar]
- 2. ) Howson , C. P. , Hiyama , T. and Wynder , E. L.The decline in gastric cancer: epidemiology of an unplanned triumph . Epidemiol. Rev. , 8 , 1 – 27 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 3. ) Chamberlain , J. , Day , N. E. , Hakama , M. , Miller , A. B. and Prorok , P. CUICC workshop of the project on evaluation of screening programmes for gastrointestinal cancer . Int. J. Cancer , 37 , 329 – 334 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 4. ) Oshima , A. , Hirata , N. , Ubukata , T. , Umeda , K. and Fujimoto , I.Evaluation of a mass screening program for stomach cancer with a case‐control study design . Int. J. Cancer , 38 , 829 – 833 ( 1986. ). [DOI] [PubMed] [Google Scholar]
- 5. ) Yamazaki , H. , Oshima , A. , Murakami , R. , Endoh , S. and Ubukata , T.A long‐terra follow‐up study of patients with gastric cancer detected by mass screening . Cancer , 63 , 613 – 617 ( 1989. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Oshima , A. , Hanai , A. and Fujimoto , I.Evaluation of a mass screening program for stomach cancer . Natl. Cancer Inst. Monogr. , 53 , 181 – 186 ( 1979. ). [PubMed] [Google Scholar]
- 7. ) Maruyama , T. , Noda , Y. , Kumamoto , Y. , Nishizawa , K. , Furuya , Y. , Iwai , K. , Urahashi , S. , Kurihara , R. , Kamata , R. and Sakata , S.Estimation of frequency, population doses and stochastic risks in stomach mass screening examinations in Japan, 1980 . Nippon Acta Radial , 47 , 971 – 982 ( 1987. ) ( in Japanese ). [PubMed] [Google Scholar]
- 8. ) Correa , P.The gastric precancerous process . Cancer Surv. , 2 , 437 – 450 ( 1983. ). [Google Scholar]
- 9. ) Morson , B. C.Carcinoma arising from areas of intestinal metaplasia in the gastric mucosa . Br. J. Cancer , 9 , 377 – 385 ( 1955. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10. ) Sipponen , P. , Kekki , M. and Siurala , M.Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma . Cancer , 52 , 1062 – 1068 ( 1983. ). [DOI] [PubMed] [Google Scholar]
- 11. ) Imai , T. , Kubo , T. and Watanabe , H.Chronic gastritis in Japanese with reference to high incidence of gastric carcinoma . J. Natl Cancer Inst. , 47 , 179 – 195 ( 1971. ). [PubMed] [Google Scholar]
- 12. ) You , W. , Blot , W. J. , Li , J. , Chang , Y. , Jin , M. , Kneller , R. , Zhang , L. , Han , Z. , Zeng , X. , Liu , W. , Zhao , L. , Correa , P. , Fraumeni , J. F. and Xu , G.Precancerous gastric lesions in a population at high risk of stomach cancer . Cancer Res. , 53 , 1317 – 1321 ( 1993. ). [PubMed] [Google Scholar]
- 13. ) Siurala , M. and Seppala , K.Atrophic gastritis as a possible precursor of gastric carcinoma and pernicious anemia . Acta Med. Scand. , 166 , 455 – 474 ( 1960. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Cheli , R. , Santi , L. , Ciancamerla , G. and Canciani , G.A clinical and statistical follow‐up study of atrophic gastritis . Dig. Dis. , 18 , 1061 – 1066 ( 1973. ). [DOI] [PubMed] [Google Scholar]
- 15. ) Kato , I. , Tominaga , S. , Ito , Y. , Kobayashi , S. , Yoshii , Y. , Matsuura , A. , Kameya , A. , Kano , T. and Ikari , A.A prospective study of atrophic gastritis and stomach cancer risk. Jpn . J. Cancer Res. , 83 , 1137 – 1142 ( 1992. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. ) Bock , O. A. A. , Arapakis , G. , Witts , L. J. and Richards , W. C. D.The serum pepsinogen level with special reference to the histology of the gastric mucosa . Gut , 4 , 106 – 111 ( 1963. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. ) Samloff , I. M. , Varis , K. , Ihamaki , T. , Siurala , M. and Rotter , J. I.Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology: a study in relatives of patients with pernicious anemia . Gas-troenterology , 83 , 204 – 209 ( 1982. ). [PubMed] [Google Scholar]
- 18. ) Miki , K. , Ichinose , M. , Shimizu , A. , Huang , S. , Oka , H. , Furihata , C. , Matsushima , T. and Takahashi , K.Serum pepsinogens as a screening test of extensive chronic gastritis . Gastroenterol. Jpn. , 22 , 133 – 141 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 19. ) Haruki , K. , Kurokawa , K. , Adachi , H. and Obata , H.Serum and gastric mucosal pepsinogens in atrophic gastritis, particularly in type A gastritis associated with pernicious anemia in Japanese . Gastroenterol. Jpn. , 28 , 359 – 366 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 20. ) Nomura , A. M. Y. , Stemmermann , G. N. and Samloff , I. M.Serum pepsinogen I as a predictor of stomach cancer . Ann. Intern. Med. , 93 , 537 – 540 ( 1980. ). [DOI] [PubMed] [Google Scholar]
- 21. ) Kabuto , M. , Imai , H. , Tsugane , S. and Watanabe , S.Correlation between atrophic gastritis prevalence and gastric cancer mortality among middle‐aged men in 5 areas in Japan . J. Epidemiol. , 3 , 35 – 39 ( 1993. ). [Google Scholar]
- 22. ) Fukao , A. , Hisamichi , S. , Ohsato , N. , Fujino , N. , Endo , N. and Iha , M.Correlation between the prevalence of gastritis and gastric cancer in Japan . Cancer Causes Control , 4 , 17 – 20 ( 1993. ). [DOI] [PubMed] [Google Scholar]
- 23. ) Watanabe , C.A clinical study on gastric mass assessment using serum pepsinogen I and II in a local population survey . Gastroenterol. Mass Surv. , 97 , 42 – 50 ( 1992. ) ( in Japanese ). [Google Scholar]
- 24. ) Miki , K. , Ichinose , M. , Ishikawa , K. B. , Yahagi , N. , Matsushima , M. , Kakei , N. , Tsukada , S. , Kido , M. , Ishihama , S. , Shimizu , Y. , Suzuki , T. and Kurokawa , K.Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer . Jpn. J. Cancer Res. , 84 , 1086 – 1090 ( 1993. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25. ) Cole , P. and Morrison , A. S.Basic issues in population screening for cancer . J. Natl. Cancer Inst. , 64 , 1263 – 1272 ( 1980. ). [PubMed] [Google Scholar]
- 26. ) Love , R. R. and Camilli , A. E.The value of screening . Cancer , 48 , 489 – 494 ( 1981. ). [DOI] [PubMed] [Google Scholar]
- 27. ) Sasamori , N. , Tamura , M. , Iwasaki , M. , Suzuki , T. , Kiyose , K. , Andoh , Y. , Hinohara , S. , Matsuda , M. and Tohkake , S.Evaluation of serum pepsinogen tests at MHTS: a new method of gastric cancer screening . Jpn. J. MHTS , 20 , 343 – 354 ( 1993. ) ( in Japanese ). [Google Scholar]
- 28. ) Miki , K.Gastric cancer screening using serum tests (stomach dry dock) — Study of the systems of the first screening for cancer‐susceptible subjects by serum pepsinogen levels and the secondary close‐examination by every‐other‐year panendoscopy . J. Gastroenterol. Mass Surv. , 107 , 19 – 30 ( 1994. ) ( in Japanese ). [Google Scholar]
- 29. ) Kimura , K.Chronological transition of the fundic‐pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach . Gastroenterology , 63 , 584 – 592 ( 1972. ). [PubMed] [Google Scholar]
- 30. ) Stemmermann , G. N. , Samloff , I. M. , Nomura , A. M. Y. and Heilbrun , L. K.Serum pepsinogens I and II and stomach cancer . Clin. Chim. Acta , 163 , 191 – 198 ( 1987. ). [DOI] [PubMed] [Google Scholar]
- 31. ) Miki , K. , Ichinose , M. , Kawamura , N. , Matsushima , M. , Ahmad , H. B. , Kimura , M. , Sano , J. , Tashiro , T. , Kakei , N. , Oka , H. , Furihata , C. and Takahashi , K.The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects . Jpn. J. Cancer Res. , 80 , 111 – 114 ( 1989. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. ) Kimura , Y. , Fujii , T. , Hamamoto , K. , Miyagawa , N. , Tsuda , K. , Tanada , S. and Lio , A.Evaluation of serum pepsinogen I and II of patients with gastric cancer . Nucl. Med. , 26 , 1127 – 1133 ( 1989. ) ( in Japanese ). [PubMed] [Google Scholar]
- 33. ) Kodoi , A. , Yoshihara , M. , Sumii , K. , Haruma , K. , Watanabe , C. , Okamoto , S. , Kawaguchi , H. , Kawamoto , K. , Tanaka , S. , Tsuda , T. and Kajiyama , G.An evaluation of screening for asymptomatic gastric cancer using serum pepsinogen I and II . J. Gastroenterol. Mass Surv. , 106 , 21 – 27 ( 1994. ) ( in Japanese ). [Google Scholar]
- 34. ) Kikuchi , S. , Wada , O. , Miki , K. , Nakajima , T. , Nishi , T. , Kobayashi , O , and Inaba , Y.Serum pepsinogen as a new marker for gastric carcinoma among young adults . Cancer , 73 , 2695 – 2702 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 35. ) Tabuchi , T. , Soma , T. , Nakada , I. , Sato , S. , Ubukata , H. , Goto , Y. , Watanabe , Y. , Nagayama , Y. , Umeda , K. , Ebine , S. and Nishikawa , T.A mass screening for gastric cancer using serum pepsinogen I and II . J. Gastroenterol. Mass Surv. , 108 , 18 – 24 ( 1994. ) ( in Japanese ). [Google Scholar]
- 36. ) Aoki , K. , Goto , T. , Kudo , M. , Yasui , T. , Shimaoka , A. and Misumi , J.A study on the distributions of serum pepsinogens in general population . Jpn. Med. J. , 3576 , 43 – 48 ( 1992. ) ( in Japanese ). [Google Scholar]
- 37. ) Kikuchi , S. , Inaba , Y. , Wada , O. , Miki , K. , Tenjin , H. , Kaneko , E. and Mizukoshi , H.Should age, sex, subjective symptoms in the stomach and past history of peptic ulcer be regarded in the evaluation of efficacy of serum pepsinogen values for use in gastric cancer mass‐screening ? J. Epidemiol , 3 , 71 – 76 ( 1993. ). [Google Scholar]
- 38. ) Ubukata , T. , Oshima , A. , Morii , T. , Nakanishi , K. , Umeda , K. and Fujimoto , I.Estimation of the validity of mass screening programs for stomach cancer and the method for that . J. Gastroenterol. Mass Surv. , 63 , 65 – 72 ( 1984. ) ( in Japanese ). [Google Scholar]
- 39. ) Murakami , R. , Tsukuma , H. , Ubukata , T. , Nakanishi , K. , Fujimoto , I. , Kawashima , T. , Yamazaki , H. and Oshima , A.Estimation of validity of mass screening program for gastric cancer in Osaka, Japan . Cancer , 65 , 1255 – 1260 ( 1990. ). [DOI] [PubMed] [Google Scholar]
- 40. ) Fukao , A. , Hisamichi , S. , Takano , A. and Sugawara , N.Accuracies of mass screening for gastric cancer: test sensitivity and program sensitivity . J. Gastroenterol. Mass Surv. , 97 , 59 – 63 ( 1992. ) ( in Japanese ). [Google Scholar]
- 41. ) Miki , N. , Oshima , A. , Kawashima , T. , Yamazaki , H. , Miyamoto , M. , Endo , S. , Okano , Y. , Morii , T. , Nakao , M. and Murakami , R.Estimation of mass screening for gastric cancer by means of a record linkage to the Osaka cancer registry . J. Gastroenterol. Mass Surv. , 97 , 64 – 68 ( 1992. ) ( in Japanese ). [Google Scholar]